Francois Lamour

Francois LAMOUR is an accomplished biotechnology professional with extensive experience in clinical research and scientific leadership. Currently serving as a CTL for a Phase I/II HNSCC Oncology study at Alentis Therapeutics, Francois co-founded HARTIS Pharma SA, holding roles as Chief Scientific Officer and Director. Previous positions include Director and Senior Clinical Project Scientist at Idorsia Pharmaceuticals Ltd and Actelion Pharmaceuticals, as well as overseeing the Medical Science responsibilities for the safety of the Ocrelizumab program at F. Hoffmann-La Roche Ltd. Francois earned a Ph.D. in Molecular Biology from Université Henri Poincaré, Nancy 1, where academic pursuits took place between 1989 and 1997.